Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Summary
The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of information obtained from blood, tissue, medical images, surveys and information from routine care to develop noninvasive diagnostic approaches that could be used as decision-making tools to effectively personalize clinical care.
Official title: Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas and Uncover Hidden Biology
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1174
Start Date
2020-02-18
Completion Date
2027-06
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
Blood Sample collection
Participants will be asked to donate blood at baseline (+/- 30 days of diagnosis date), 4-6 weeks post-surgery, if applicable, and at the time of follow-up (approximately 1 year and approximately 2 years after baseline).
Tissue sample collection
At the time of tissue biopsy and surgical resection (if applicable), pancreatic tumor tissue, muscle, fat, tissue from site of metastasis, and cyst fluid (if applicable) will be collected.
Data collection
Participants will be asked to complete questionnaires at baseline and at 1 year and 2 year follow-ups.
Locations (3)
Florida Research Institute (FRI)
Lakewood Rch, Florida, United States
Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital
Miami, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States